Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

A UCO team has applied the genome editing technique, which garnered a Nobel Prize in Chemistry in 2020, to unravel the ...

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Nobel Prize Winner & ERS Genomics Co-Founder, said: "Our new express license platform represents an exciting step forward in democratizing access to the foundational CRISPR/Cas9 IP. By simplifying ...

In October, CRISPR Therapeutics co-founder Emmanuelle Charpentier and Intellia co-founder Jennifer Doudna shared the 2020 Nobel Prize in Chemistry for their work on CRISP/Cas9. At JPM Week 2025 in ...

CRISPR-Cas9 technology – which allows scientists to precisely cut and modify DNA at specific locations within a genome – was discovered by Jennifer Doudna and Emmanuelle Charpentier in 2012.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment ... was approved in several countries to treat eligible patients with ...